Profil
Dr. Pamela Bassett, MD MBA, is Senior Equity Analyst at Maxim Group LLC.
She was previously employed as Independent Director at iBio, Director-Business Development by Enzon Pharmaceuticals, Inc., Founder & President at BioTrend Corp, Founder & President at Stat Systems, Inc., Managing Director & Senior Equity Analyst by Cantor Fitzgerald Securities.
Dr. Bassett received her M.B.A.
from Wharton Graduate School, University of Pennsylvania, completed a Residency in Anesthesiology at Drexel University College of Medicine, and received her D.M.D.
from Tufts University School of Dental Medicine and B.A.
in Biology from Oakland University.
Anciens postes connus de Pamela Bassett
| Sociétés | Poste | Fin |
|---|---|---|
Maxim Group LLC
 Maxim Group LLC Investment Banks/BrokersFinance Founded in 2002, Maxim Group LLC is a registered broker/dealer located in New York City. The firm provides an array of financial services including: investment banking, equity research, private wealth management, structured products and global institutional equity, fixed-income and derivative sales and trading to a diverse range of corporate clients, institutional investors and high net-worth individuals. Maxim Group's niche is emerging-growth companies in a variety of sectors including healthcare, technology, retail and others. They utilize a fundamental, bottom-up approach to investment recommendations. The firm combines rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. The firm focuses on under-covered, small- to-mid-cap companies where valuation levels may be out of sync with fundamental trends. Maxim's coverage universe often represents attractive niche industries where stocks tend to be inefficient. This research coverage fills a void created by the downsized research ranks and shrinking coverage of small- to mid-cap stocks by large investment banks. Maxim Group is a member of FINRA, the MSRB, the SIPC, the ISE, NASDAQ and NYSE Arca. | Analyst-Equity | 01/05/2014 |
| IBIO, INC. | Directeur/Membre du Conseil | 01/12/2011 |
| Stat Systems, Inc. | Fondateur | - |
| ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| BioTrend Corp. | Fondateur | - |
Formation de Pamela Bassett
| Tufts University | Doctorate Degree |
| Oakland University (Michigan) | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| IBIO, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Cantor Fitzgerald Securities
 Cantor Fitzgerald Securities Investment Banks/BrokersFinance Cantor Fitzgerald Securities (CFS) is a financial services provider headquartered in New York City and was founded in 1945. They are a subsidiary of Cantor Fitzgerald LP and their ultimate parent is CF Group Management, Inc. CFS offers an array of financial products and services in the equity and fixed-income capital markets. The firm provides sales and trading, investment banking, asset management, market commentary and market data. | Finance |
| BioTrend Corp. | |
| Stat Systems, Inc. | |
Maxim Group LLC
Maxim Group LLC Investment Banks/BrokersFinance Founded in 2002, Maxim Group LLC is a registered broker/dealer located in New York City. The firm provides an array of financial services including: investment banking, equity research, private wealth management, structured products and global institutional equity, fixed-income and derivative sales and trading to a diverse range of corporate clients, institutional investors and high net-worth individuals. Maxim Group's niche is emerging-growth companies in a variety of sectors including healthcare, technology, retail and others. They utilize a fundamental, bottom-up approach to investment recommendations. The firm combines rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. The firm focuses on under-covered, small- to-mid-cap companies where valuation levels may be out of sync with fundamental trends. Maxim's coverage universe often represents attractive niche industries where stocks tend to be inefficient. This research coverage fills a void created by the downsized research ranks and shrinking coverage of small- to mid-cap stocks by large investment banks. Maxim Group is a member of FINRA, the MSRB, the SIPC, the ISE, NASDAQ and NYSE Arca. | Finance |
